Sarah Tabrizi
Prof Sarah Joanna Tabrizi FMedSci | |
---|---|
Sarah Tabrizi in 2013 | |
Residence | London, UK |
Fields | Neuroscience |
Institutions |
UCL Institute of Neurology; National Hospital for Neurology and Neurosurgery |
Notable students | Edward Wild (neuroscientist) |
Known for | Research into neurodegeneration, particularly Huntington's disease |
Notable awards | Fellowship of the Academy of Medical Sciences, 2014 |
Spouse | Michael Nath |
Website hdresearch |
Sarah Tabrizi FMedSci is a British neurologist and neuroscientist in the field of neurodegeneration, particularly Huntington's disease. She is a Professor at the UCL Institute of Neurology; the founder and director of the UCL Huntington's Disease Centre; and an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London, where she established the Multidisciplinary Huntington's Disease Clinic.[1][2][3]
Education
Tabrizi studied biochemistry at Heriot-Watt University followed by medicine at Edinburgh University where she graduated with the Gold Medal (Ettles Scholar) for top student.[1] She obtained a PhD at University College London in 2000.[4]
Research
Tabrizi is distinguished for her work on Huntington's disease pathobiology, biomarkers, outcome measures and clinical trials.[5][6] She led the influential multi-site TRACK-HD cohort study of Huntington's disease that established a battery of clinical trial outcome measures.[5] She is the lead Clinical Investigator for the first clinical trial of a 'gene silencing' or huntingtin-lowering drug in Huntington's disease patients.[7] Tabrizi gave a keynote presentation at the 2016 Google Zeitgeist Minds conference about the trial, and the prospect of gene silencing for neurodegenerative disease.[8]
As of November 2016, Tabrizi had authored over 300 publications, with over 12,500 citations for her research.[9]
Awards and honours
- Elected Fellow of the Academy of Medical Sciences (2014).[10]
- Member of the Wellcome Trust Expert Review Group on Cellular and Molecular Neuroscience[11]
- Associate Editor, Journal of Huntington's Disease[12]
- Elected Fellow of the Royal College of Physicians (2007).[4]
Personal life
Tabrizi lives in London with her husband, the author Michael Nath.[4]
References
- 1 2 "Iris View Profile". IRIS - UCL. Retrieved 5 May 2016.
- ↑ "UCL Huntington's Disease Research". hdresearch.ucl.ac.uk.
- ↑ "Prof Sarah Tabrizi". www.uclh.nhs.uk.
- 1 2 3 "Who's Who 2016 - Tabrizi, Prof. Sarah Joanna". Who's Who 2016. Retrieved 6 May 2016.
- 1 2 Shetty, Priya (June 2012). "Sarah Tabrizi: tracking Huntington's disease". The Lancet. 379 (9831): 2043. doi:10.1016/S0140-6736(12)60884-8.
- ↑ Mohammadi, Dara (July 2015). "Fast-forwarding treatment for neurodegenerative disorders". The Lancet Neurology. 14 (7): 687–688. doi:10.1016/S1474-4422(15)00110-6.
- ↑ Gallagher, James. "Landmark Huntington's trial starts". BBC News. BBC News. Retrieved 5 May 2016.
- ↑ "Sarah Tabrizi - The Human Revolution". Zeitgeist Minds.
- ↑ "Sarah J Tabrizi - Google Scholar Citations". scholar.google.co.uk.
- ↑ "Fellow - Academy of Medical Sciences". www.acmedsci.ac.uk.
- ↑ "Governance - Wellcome". wellcome.ac.uk.
- ↑ "Journal of Huntington's Disease". www.iospress.nl. Retrieved 13 June 2016.
External links
- UCL Huntington's Disease Centre
- Google Scholar Citations - Sarah J Tabrizi
- Sarah Tabrizi profile at UCL Iris